UK Rapid Test Consortium
The UK Rapid Test Consortium (UK-RTC) is a United Kingdom industry consortium created to produce a lateral flow rapid test for COVID-19. Rapid tests are a form of COVID-19 testing technology that was originally developed from significant investment by the United Kingdom government to develop new forms of COVID-19 testing that provided advantages over existing forms such as PCR. Its members include Abingdon Health, BBI Solutions, CIGA Healthcare, Omega Diagnostics, and Oxford University.[1][2]
In 2020, the consortium developed the AbC-19 rapid test to meet UK government requirements for a rapid testing solution.[2] The government ordered 1 million of the UK-RTC's rapid tests in October 2020.[3]
Distribution
CIGA Healthcare will be responsible for assembly and distribution, and has also been awarded distribution to the US after recent FDA approval.[4]
References
- "rapidmicrobiology UK Begin At-Home COVID-19 Antibody Testing Programme". www.rapidmicrobiology.com. Retrieved 13 November 2020.
- "Industry responds to call to arms to build British diagnostics industry at scale". GOV.UK. Retrieved 13 November 2020.
- "Government invests in UK-developed antibody tests from UK Rapid Test Consortium". GOV.UK. Retrieved 13 November 2020.
- "Yorkshire developed Covid-19 test approved for use in North America".
COVID-19 pandemic in the United Kingdom, Crown Dependencies and British Overseas Territories | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| |||||||||
| Locations |
| ||||||||
| Impact |
| ||||||||
| Science and healthcare |
| ||||||||
| Responses |
| ||||||||
| Legislation |
| ||||||||
| Timelines | |||||||||
| Advisory bodies |
| ||||||||
| Key people |
| ||||||||
| Media depictions |
| ||||||||
| See also |
| ||||||||
.svg.png.webp){kind=small} COVID-19 portal | |||||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.